Red meat intake, doneness, polymorphisms in genes that encode carcinogen-metabolizing enzymes, and colorectal cancer risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 11, 2008, Pages 3098-3107

  Cotterchio, Michelle ^a,b   Boucher, Beatrice A ^a   Manno, Michael ^a   Gallinger, Steven ^c   Okey, Allan B ^b   Harper, Patricia A ^d  

^a Population Studies and Surveillance   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; CYTOCHROME P450; CYTOCHROME P450 1B1; CYTOCHROME P450 2C9; CYTOCHROME P450 2E1; GLUCURONOSYLTRANSFERASE; GLUTATHIONE TRANSFERASE;

ADULT; AGED; ARTICLE; CANADA; CANCER DIAGNOSIS; CANCER REGISTRY; CANCER RISK; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FOOD INTAKE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; QUESTIONNAIRE; RED MEAT;

ADULT; AGED; ARYL HYDROCARBON HYDROXYLASES; ARYLSULFOTRANSFERASE; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; COOKERY; DIET; EATING; FEMALE; GENOTYPE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MEAT PRODUCTS; MIDDLE AGED; ONTARIO; POLYMORPHISM, GENETIC; REGISTRIES; RISK FACTORS;

EID: 55849128161     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0341     Document Type: Article

References (69)

1. National Cancer Institute of Canada: Canadian Cancer Statistics 2006 (Table 15); Toronto, Canada; 2006.
2. Carstensen B, Soll-Johanning H, Villadsen E, Sondergaard JO, Lynge E. Familial aggregation of colorectal cancer in the general population. Int J Cancer 1996;68:428-35.
3. de Leon MP, Pedroni M, Benatti P, et al. Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis. Gut 1999;45:32-8.
4. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-70.
5. Larsson S, Wolk A. Meat consumption and risk of colorectal cancer: a meta-analysis of prospective studies. Int J Cancer 2006;119:2657-64.
6. Sandhu M, White I, McPherson K. Systematic review of the prospective cohort studies on meat consumption and colorectal cancer risk: a meta-analytical approach. Cancer Epidemiol Biomarkers Prev 2001;10:439-46.
7. Gerhardsson de Verdier M, Hagman U, Peters R, Steineck G, Övervik E. Meat, cooking methods and colorectal cancer: a case-referent study in Stockholm. Int J Cancer 1991;49:520-5.
8. Peters R, Pike M, Garabrant D, Mack T. Diet and colon cancer in Los Angeles, California. Cancer Causes Control 1992;3:457-73.
9. Larsson S, Rafter J, Holmberg L, Bergkvist L, Wolk A. Red meat consumption and risk of cancers of the proximal colon, distal colon and rectum: the Swedish Mammography Cohort. Int J Cancer 2005;113:829-34.
10. English D, MacInnis R, Hodge A, Hopper J, Haydon A, Giles G. Red meat, chicken, and fish consumption and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2004;13:1509-14.
11. Norat T, Lukanova A, Ferrari P, Riboli E. Meat consumption and colorectal cancer risk: dose-response meta-analysis of epidemiological studies. Int J Cancer 2002;98:241-56.
12. Norat T, Bingham S, Ferrari P, et al. Meat, fish, and colorectal cancer risk: the European Prospective Investigation into Cancer and Nutrition. J Natl Cancer Inst 2005;97:906-16.
13. Butler L, Sinha R, Millikan R, et al. Heterocyclic amines, meat intake, and association with colon cancer in a population-based study. Am J Epidemiol 2003;157:434-45.
14. Chiu B, Ji B, Dai Q, et al. Dietary factors and risk of colon cancer in Shanghai, China. Cancer Epidemiol Biomarkers Prev 2003;12:201-8.
15. Schut H, Snyderwine E. DNA adducts of HCA food mutagens: implications for mutagenesis and carcinogenesis [review]. Carcinogenesis 1999;20:353-68.
16. Hu J, Morrison H, Mery L, et al. Diet and vitamin or mineral supplementation and risk of colon cancer by subsite in Canada. Eur J Cancer Prev 2007;16:275-91.
17. Nowell S, Coles B, Sinha R, et al. Analysis of total meat intake and exposure to individual heterocyclic amines in a case-control study of colorectal cancer: contribution of metabolic variation to risk. Mutat Res 2002;506:175-85.
18. Murtaugh M, Ma K, Sweeney C, Caan B, Slattery M. Meat consumption patterns and preparation, genetic variants of metabolic enzymes, and their association with rectal cancer in men and women. J Nutr 2004;134:776-84.
19. Le Marchand L, Hankin J, Pierce L, et al. Well-done red meat, metabolic phenotypes and colorectal cancer in Hawaii. Mutat Res 2002;506-507:205-14.
20. Sachse C, Smith G, Wilkie M, et al. A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcinogenesis 2002;23:1839-49.
21. Nebert D, Ingelman-Sundberg M, Daly A. Genetic epidemiology of environmental toxicity and cancer susceptibility: human allelic polymorphisms in drug-metabolizing enzyme genes, their functional importance, and nomenclature issues. Drug Metab Rev 1999;31:467-87.
22. Zheng W, Xie D, Jin F, et al. Genetic polymorphism of cytochrome P450-1B1 and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2000;9:147-50.
23. Burchell B, Soars M, Monaghan G, Cassidy A, Smith D, Ethell B. Drug-mediated toxicity caused by genetic deficiency of UDP- glucuronosyltransferases. Toxicol Lett 2000;112/113:333-40.
24. Strange R, Jones P, Fryer A. Glutathione S-transferase: genetics and role in toxicology. Toxicol Lett 2000;112-3:357-63.
25. Thompson P, Ambrosone C. Molecular epidemiology of genetic polymorphisms in estrogen metabolizing enzymes in human breast cancer. J Natl Cancer Inst Monogr 2000;27:125-34.
26. Dean B, Chang S, Doss GA, King C, Thomas PE. Glucuronidation, oxidative metabolism, and bioactivation of enterolactone in rhesus monkeys. Arch Biochem Biophys 2004;429:244-51.
27. Guengerich FP, Kim DH, Iwasaki M. Role of human cytochrome P450 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol 1991;4:168-79.
28. Guengerich FP. Metabolism of chemical carcinogens. Carcinogenesis 2000;21:345-51.
29. Cross A, Sinha R. Meat-related mutagens/carcinogens in the etiology of colorectal cancer. Environ Mol Mutagen 2004;44:44-5.
30. Chen J, Stampfer M, Hough H, et al. A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer. Cancer Res 1998;58:3307-11.
31. Le Marchand L, Donlon T, Seifried A, Wilkens L. Red meat intake, CYP2E1 genetic polymorphisms, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:1019-24.
32. Perera F, Weinstein I. Molecular epidemiology: recent advances and future directions. Carcinogenesis 2000;21:517-24.
33. Williams JA. Single nucleotide polymorphisms, metabolic activation and environmental carcinogenesis: why molecular epidemiologists should think about enzyme expression. Carcinogenesis 2001;22:209-14.
34. Murtaugh M, Sweeney C, Ma K, Caan B, Slattery M. The CYP1A1 genotype may alter the association of meat consumption patterns and preparation with the risk of colorectal cancer in men and women. J Nutr 2005;135:179-86.
35. Kampman E, Slattery M, Bigler J, et al. Meat consumption, genetic susceptibility, and colon cancer risk: a United States multicenter case-control study. Cancer Epidemiol Biomarkers Prev 1999;8:15-24.
36. Chan A, Tranah G, Giovannucci E, Willett W, Hunter D, Fuchs C. Prospective study of N-acetyltransferase-2 genotypes, meat intake, smoking and risk of colorectal cancer. Int J Cancer 2005;115:648-52.
37. Turner F, Smith G, Sachse C, et al. Vegetable, fruit and meat consumption and potential risk modifying genes in relation to colorectal cancer. Int J Cancer 2004;112:259-64.
38. Lilla C, Verla-Tebit E, Risch A, et al. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and red meat. Cancer Epidemiol Biomarkers Prev 2006;15:99-107.
39. Lilla C, Risch A, Verla-Tebit E, et al. SULT1A1 genotype and susceptibility to colorectal cancer. Int J Cancer 2006;120:201-6.
40. Küry S, Buecher B, Robiou-du-Pont S, et al. Combinations of cytochrome P450 gene polymorphisms enhancing the risk for sporadic colorectal cancer related to red meat consumption. Cancer Epidemiol Biomarkers Prev 2007;16:1460-7.
41. Butler L, Duguay Y, Millikan R, et al. Joint effects between UGT1A7 genotype and dietary carcinogen exposure on risk of colon cancer. Cancer Epidemiol Biomarkers Prev 2005;14:1626-32.
42. Newcomb P, Baron J, Cotterchio M, et al.; for the Colon Cancer Family Registry. Colon cancer family registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prev 2007;16:2331-43.
43. Cotterchio M, McKeown-Eyssen G, Sutherland H, et al. Ontario Familial Colon Cancer Registry: methods and first year response rates. Chronic Dis Can 2000;21:81-6.
44. Cotterchio M, Manno M, Klar N, McLaughlin J, Gallinger S. Colorectal screening is associated with reduced colorectal cancer risk: a case-control study within the population-based Ontario Familial Colorectal Cancer Registry. Cancer Causes Control 2005;16:865-75.
45. Cotterchio M, Boucher B, Manno M, Gallinger S, Okey A, Harper P. Dietary phytoestrogen intake is associated with reduced colorectal cancer risk. J Nutr 2006;136:3046-53.
46. International Classification of Diseases. Manual of the international statistical classification of disease, injuries, and causes of death. 9th Revision Conference. Geneva (Switzerland): WHO; 1977.
47. Holowaty EJ, Lee G, Dale D, Chong N. A reabstraction study to estimate the accuracy and completeness of data elements in the Ontario Cancer Registry. Niagara-on-the-Lake (Ontario): American Association of Central Cancer Registries; 1994.
48. Vasen H, Mecklin J, Khan P, Lynch H. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991;34:424-5.
49. Stram DO, Hankin JH, Wilkens LR, et al. Calibration of the dietary questionnaire for a multiethnic cohort in Hawaii and Los Angeles. Am J Epidemiol 2000;151:358-70.
50. Schlesselman JJ. Case-control studies: design, conduct, analysis. New York: Oxford University Press; 1982.
51. Hosmer DW, Lemeshow S. Applied logistic regression. New York: Wiley; 2000.
52. Maldonado G, Greenland S. Simulation study by confounder-selection strategies. Am J Epidemiol 1993;138:923-36.
53. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health 1989;79:340-9.
54. Shimada T, Watanabe J, Kawajiri K, et al. Catalytic properties of polymorphic human cytochrome P450 1B1 variants. Carcinogenesis 1999;20:1607-13.
55. Bailey LR, Roodi N, Dupont WD, Parl FF. Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer. Cancer Res 1998;58:5038-41.
56. Stoliov I, Akarsu AN, Alozie I, et al. Sequence analysis and homology modeling suggest that primary congenital glaucoma on 2p21 results from mutations disrupting either the hinge region or the conserved core structures of cytochrome P4501B1. Am J Hum Genet 1998;62:573-84.
57. Murray M. Drug-mediated inactivation of cytochrome P450. Clin Exp Pharmacol Physiol 1997;24:465-70.
58. Fritsche E, Bruning T, Jonkmanns C, Ko Y, Bolt HM, Abel J. Detection of cytochrome P450 1B1 BfrI polymorphism: genotype distribution in healthy German individuals and in patients with colorectal cancer. Pharmacogenetics 1999;9:405-8.
59. Lindsay J, Wang L, Li Y, Zhou S. Structure, function and polymorphism of human cytosolic sulfertransferases. Curr Drug Metab 2008;9:99-105.
60. Beef Information Centre (http://www.beefinfo.org/nutrient_data.cfm#faq11) .
61. Moreno V, Glatt H, Guino E, et al. Polymorphisms in SULT1A1 and SULT1A2 are not related to colorectal cancer [letter]. Int J Cancer 2004;113:683-6.
62. Skog K, Johansson M, Jagerstad M. Carcinogenic HCA in model systems and cooked foods: a review on formation, occurrence and intake. Food Chem Toxicol 1998;36:879-96.
63. Gonzalez F, Gelboin H. Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins. Drug Metab Rev 1994;26:165-83.
64. Okey AB, Harper PA, Grant DM, Hill RP. Chemical and radiation carcinogenesis. In: Tannock IF, Hill RP, Bristow RG, Harrington L, editors. The basic science of oncology. 4th ed. Toronto: McGraw-Hill; 2005. p. 25-48.
65. Malfatti MA, Felton JS. N-glucuronidation of 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine (PhIP) and N-hydroxy-PhIP by specific human UDP-glucuronosyltransferases. Carcinogenesis 2001;22:1087-93.
66. Hammons G, Milton D, Stepps K, Guengerich F, Tukey R, Kadlubar F. Metabolism of carcinogenic heterocyclic and aromatic amines by recombinant human cytochrome P450 enzymes. Carcinogenesis 1997;18:851-4.
67. Gonzalez FJ. T he use of gene knockout mice to unravel the mechanisms of toxicity and chemical carcinogenesis. Toxicol Lett 2001;120:199-208.
68. Malfatti MA, Dingley KH, Nowell-Kadlubar S, et al. The urinary metabolite profile of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5- b]pyridine is predictive of colon DNA adducts after a low-dose exposure in humans. Cancer Res 2006;66:10541-7.
69. Slattery ML, Edwards SL, Samowitz W. Stage of colon cancer at diagnosis: implications for risk factor associations? Int J Epidemiol 1998;27:382-7.